PERRY MARK L

CIK 00011902706 companiesSANTA CLARA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001190270

Recent Transactions

50 trades

Sale
NVIDIA CORP$NVDA
Common Stock
2024-04-02$887.89/sh−7,000→ 116,000 total
Sale
NVIDIA CORP$NVDA
Common Stock
2024-02-23$796.45/sh−15,000→ 123,000 total
Award
NVIDIA CORP$NVDA
Common Stock
2023-06-23+650→ 13,612 total
Gift
NVIDIA CORP$NVDA
Common Stock
2023-05-26−2,000→ 138,000 total
Gift
NVIDIA CORP$NVDA
Common Stock
2023-05-26+1,000→ 1,000 total
Gift
NVIDIA CORP$NVDA
Common Stock
2023-05-26+1,000→ 1,000 total
Sale
NVIDIA CORP$NVDA
Common Stock
2023-02-27$236.25/sh−6,100→ 147,100 total
Sale
NVIDIA CORP$NVDA
Common Stock
2023-02-27$237.36/sh−5,700→ 141,400 total
Sale
NVIDIA CORP$NVDA
Common Stock
2023-02-27$238.00/sh−1,400→ 140,000 total
Sale
NVIDIA CORP$NVDA
Common Stock
2023-02-27$235.31/sh−6,800→ 153,200 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−15,000→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Common Stock
2022-10-05−37,865→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,247→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-10-05−3,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,600→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−7,500→ 0 total
Disposition to Issuer
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-10-05−5,600→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-14−3,600→ 0 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2022-06-14+3,600→ 3,600 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2022-06-14+3,600→ 37,865 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-14+5,600→ 5,600 total
Award
NVIDIA CORP$NVDA
Common Stock
2022-06-03+1,438→ 12,962 total
Sale
NVIDIA CORP$NVDA
Common Stock
2022-03-18$265.49/sh−100→ 11,524 total
Sale
NVIDIA CORP$NVDA
Common Stock
2022-03-18$263.67/sh−12,100→ 14,340 total
Sale
NVIDIA CORP$NVDA
Common Stock
2022-03-18$262.90/sh−1,800→ 26,440 total
Sale
NVIDIA CORP$NVDA
Common Stock
2022-03-18$264.92/sh−2,716→ 11,624 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-17+3,600→ 3,600 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-17+5,600→ 5,600 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2021-06-17+3,037→ 34,265 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2021-06-17−3,037→ 0 total
Award
NVIDIA CORP$NVDA
Common Stock
2021-06-04+429→ 7,060 total
Sale
NVIDIA CORP$NVDA
Common Stock
2021-04-05$556.46/sh−4,704→ 8,031 total
Sale
NVIDIA CORP$NVDA
Common Stock
2021-04-05$556.98/sh−1,400→ 6,631 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−21,800→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition from Tender
MyoKardia, Inc.
Common Stock
2020-11-17−29,508→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−6,600→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−11,000→ 0 total
Disposition to Issuer
MyoKardia, Inc.
Stock Option (Right to buy)
2020-11-17−3,000→ 0 total
Award
MyoKardia, Inc.
Restricted Stock Units
2020-06-18+1,800→ 1,800 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2020-06-18+3,000→ 3,000 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-06-17+4,800→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-06-17+4,800→ 31,228 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-06-17+3,037→ 3,037 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-17+5,247→ 5,247 total
Exercise/Conversion
MyoKardia, Inc.
Restricted Stock Units
2020-06-13−2,300→ 0 total
Exercise/Conversion
MyoKardia, Inc.
Restricted Stock Units
2020-06-13+2,300→ 0 total
Exercise/Conversion
MyoKardia, Inc.
Common Stock
2020-06-13+2,300→ 27,708 total
Exercise/Conversion
MyoKardia, Inc.
Common Stock
2020-06-13+2,300→ 27,708 total

Companies

Recent Filings

Address

C/O NVIDIA CORPORATION 2701 SAN TOMAS EXPRESSWAY

SANTA CLARA, CA, 95050

View on SEC.gov